Mitochondrial Fission Mediates Endothelial Inflammation

Area of Science:

• Cardiovascular Biology
• Cellular Biology
• Inflammation Research

Background:

• Endothelial inflammation and mitochondrial dysfunction are key in cardiovascular diseases.
• Mitochondrial dysfunction is linked to mitochondrial fission, regulated by dynamin-related protein 1 (Drp1).
• Nuclear factor-kappa B (NF-κB) is a critical regulator of endothelial inflammation.

Purpose of the Study:

• To investigate the causal link between mitochondrial fission and NF-κB activation in endothelial inflammatory responses.
• To elucidate the role of Drp1 in mediating inflammation-induced mitochondrial fragmentation.
• To explore the reciprocal relationship between NF-κB signaling and mitochondrial dynamics.

Main Methods:

• Utilized cultured endothelial cells and Drp1 heterodeficient/silenced mice models.
• Assessed mitochondrial fragmentation, NF-κB activation, and inflammatory markers like VCAM-1.
• Investigated the effects of inhibiting Drp1 and canonical NF-κB signaling pathways.

Main Results:

• Pro-inflammatory stimuli (TNF-α, LPS) induced mitochondrial fragmentation in endothelial cells.
• Inhibition of Drp1 suppressed mitochondrial fission, NF-κB activation, and leukocyte adhesion.
• Inhibition of NF-κB signaling reduced endothelial mitochondrial fission, implicating NF-κB p65/RelA in fission.
• Salicylate maintained mitochondrial balance by inhibiting NF-κB.

Conclusions:

• A novel mechanism links the canonical NF-κB pathway and mitochondrial fission in regulating endothelial inflammation.
• Drp1 plays a crucial role in mediating inflammatory responses through mitochondrial dynamics.
• Targeting the interplay between NF-κB and mitochondrial fission presents a potential therapeutic strategy for cardiovascular diseases.